Celgene Corp (CELG) 116.98 $CELG SmarTrend Watching for

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 116.98 $CELG

SmarTrend Watching for Potential Pullback in Shares of Celgene After 4.28% Gain
Comtex SmarTrend(R) - 2 hrs 6 mins ago
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $110.88 to a high of $118.50. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of $118.41 on volume of 8.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 116.98 (+4.79)

After Yesterday's Rally of 4.28% Shares Could Potentially Pullback
Comtex SmarTrend(R) - 2 hrs 6 mins ago
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $110.88 to a high of $118.50. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of $118.41 on volume of 8.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 116.98 (+4.79)

Jim Cramer -- Microsoft, General Mills, WhiteWave Are Buying Opportunities
at The Street - Wed Oct 07, 11:59AM CDT
Jim Cramer answers viewers questions from social media on the floor of the New York Stock Exchange.
BLUE: 94.30 (-0.50), BIIB: 279.24 (+3.25), FB: 92.40 (-0.40), XOM: 79.20 (+1.31), AMGN: 148.05 (+6.83), LLY: 83.99 (-0.18), BMY: 60.55 (+0.67), INTC: 32.31 (+0.57), CELG: 116.98 (+4.79), WWAV: 41.76 (-0.20), MSFT: 46.80 (+0.05), TWTR: 29.83 (+2.21), CVX: 88.12 (+1.13), GIS: 55.72 (+0.02)

Shares of CELG Down 8.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 07, 10:24AM CDT
SmarTrend identified a Downtrend for Celgene (NASDAQ:CELG) on August 7th, 2015 at $126.90. In approximately 2 months, Celgene has returned 8.92% as of today's recent price of $115.58.
CELG: 116.98 (+4.79)

Jim Cramer -- Take Cisco Over Juniper and Buy Celgene, Too
at The Street - Wed Oct 07, 10:24AM CDT
Cramer likes Cisco Systems' low valuation and exposure to the cyber security industry. He loves Celgene for its above-average growth and reasonable valuation.
IBB: 307.79 (+5.88), CSCO: 27.54 (+0.31), CELG: 116.98 (+4.79), JNPR: 29.42 (+1.00)

Stock Market News for October 07, 2015
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 9:10AM CDT
Benchmarks finished mixed on Tuesday after a selloff in healthcare stocks offset gains in energy and materials shares
KMI: 32.14 (+0.36), BIIB: 279.24 (+3.25), MON: 88.06 (-0.02), AMGN: 148.05 (+6.83), XOM: 79.20 (+1.31), COP: 55.27 (+0.13), SLB: 75.35 (+1.41), CELG: 116.98 (+4.79), LYB: 95.59 (+1.96), GILD: 100.27 (+2.73), DD: 55.38 (+0.17), CVX: 88.12 (+1.13), DOW: 47.49 (+0.41), REGN: 485.76 (+25.94), ECL: 118.27 (+1.08)

Celgene (CELG) Crosses Pivot Point Resistance at $115.86
Comtex SmarTrend(R) - Wed Oct 07, 9:04AM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $112.26 today and has reached the first level of resistance at $115.86. Investors may be interested in a cross of the next upside pivot targets of $119.53 and $126.80.
CELG: 116.98 (+4.79)

Biotech's Bloodbath Is Ridiculous; Here's Why
George Budwell, The Motley Fool - Motley Fool - Wed Oct 07, 7:43AM CDT
Biotech has had an absolutely terrible time over the last few months, with most of the top dogs in the industry seeing their share prices get some pretty ugly haircuts: GILD data by YCharts . The odd and perhaps ridiculous part of...
GILD: 100.27 (+2.73), CELG: 116.98 (+4.79)

Drug Stocks' Earnings Power Won't Go Away
at The Street - Wed Oct 07, 4:23AM CDT
Before you sell them, ask yourself at what multiple you sell.
AGN: 268.99 (-3.89), JNJ: 94.98 (+1.56), ABT: 40.63 (+0.74), GILD: 100.27 (+2.73), AMGN: 148.05 (+6.83), RCPT: 231.96 (-0.03), TEVA: 58.55 (+0.58), REGN: 485.76 (+25.94), CELG: 116.98 (+4.79)

DuPont and Illumina are big market movers
AP - Tue Oct 06, 3:44PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
GE: 27.77 (+0.48), SWKS: 83.61 (+2.90), ILMN: 145.94 (+0.13), TCS: 12.04 (-0.63), CELG: 116.98 (+4.79), PEP: 98.52 (+1.45), AA: 10.94 (-0.04), NWL: 41.66 (+0.72), ONCE: 44.81 (-5.59), DE: 78.89 (+0.45), DD: 55.38 (+0.17), BP: 35.71 (+1.40), TWTR: 29.83 (+2.21), GIS: 55.72 (+0.02)

Biotech stocks fall on trade deal and drug price scrutiny
By MARLEY JAY - AP - Tue Oct 06, 3:11PM CDT
NEW YORK (AP) — Biotech stocks slipped Tuesday on concerns about patent protection overseas and on continued scrutiny of the cost of some medications.
VRTX: 109.40 (-0.06), GILD: 100.27 (+2.73), AMGN: 148.05 (+6.83), REGN: 485.76 (+25.94), MS: 32.93 (+0.57), CELG: 116.98 (+4.79)

Jim Cramer -- Peltz Will Be Great for GE, Amazon Can't Hurt Apple TV
at The Street - Tue Oct 06, 11:19AM CDT
On Tuesday, Jim Cramer discussed what's ahead for the stock market, why you should own General Electric, and why he's a fan of Columbia Sportswear.
BIIB: 279.24 (+3.25), AMZN: 541.94 (+4.46), GE: 27.77 (+0.48), VFC: 69.67 (-0.08), COLM: 57.77 (+0.57), XOM: 79.20 (+1.31), LULU: 54.00 (+2.26), PEP: 98.52 (+1.45), CELG: 116.98 (+4.79), JNJ: 94.98 (+1.56), AA: 10.94 (-0.04), GILD: 100.27 (+2.73), DD: 55.38 (+0.17), AAPL: 110.78 (-0.53)

'Mad Money' Lightning Round: Hurray, Change Is Finally Coming to Twitter
at The Street - Tue Oct 06, 5:00AM CDT
Cramer wants you to avoid Sprint, Intrexon and Motorola Solutions.
MSI: 69.79 (+0.60), SWIR: 23.70 (+1.20), GOGO: 16.97 (+0.97), SWKS: 83.61 (+2.90), S: 4.59 (+0.16), IP: 40.29 (+0.44), XON: 33.71 (+2.64), AMAG: 39.88 (+1.04), TWTR: 29.83 (+2.21), CELG: 116.98 (+4.79), UAL: 51.58 (+0.80)

'Fast Money' Recap: Have Markets Risen Too Far Too Fast?
at The Street - Tue Oct 06, 4:00AM CDT
The trading panel discussed Dupont, Norman Peltz and if today's stock market is acting like 2011's.
SPY: 199.41 (+1.62), GILD: 100.27 (+2.73), DD: 55.38 (+0.17), IBB: 307.79 (+5.88), CELG: 116.98 (+4.79)

Jim Cramer's 'Mad Money' Recap: Here's Where the Bear Tide Is Turning
at The Street - Mon Oct 05, 7:10PM CDT
When the facts change, investors need to change their minds, Cramer says.
MNK: 65.27 (+2.29), SWIR: 23.70 (+1.20), GE: 27.77 (+0.48), SWKS: 83.61 (+2.90), IP: 40.29 (+0.44), XON: 33.71 (+2.64), TGTX: 12.37 (-0.03), WYNN: 71.99 (+4.14), LVS: 45.82 (+0.94), SLB: 75.35 (+1.41), CELG: 116.98 (+4.79), UAL: 51.58 (+0.80), MSI: 69.79 (+0.60), GOGO: 16.97 (+0.97), S: 4.59 (+0.16), DD: 55.38 (+0.17), AMAG: 39.88 (+1.04), TWTR: 29.83 (+2.21), SLCA: 16.03 (+0.25)

Cramer -- Twitter Investors Should Cheer for Dorsey as CEO
at The Street - Mon Oct 05, 11:41AM CDT
Jim Cramer said Jack Dorsey is a 'stabilization force' who cares about Twitter's shareholders, workers and tweeters, though he wishes Dorsey would resign from Square to focus on Twitter.
WFM: 33.94 (+0.41), DO: 19.95 (+0.54), HAL: 39.86 (+0.82), PAY: 28.91 (-0.17), OXY: 71.89 (+0.30), TWTR: 29.83 (+2.21), SLB: 75.35 (+1.41), MCO: 99.44 (+0.34), CELG: 116.98 (+4.79)

3 Biotech Bargains to Buy
Todd Campbell, The Motley Fool - Motley Fool - Mon Oct 05, 7:02AM CDT
Biotechnology stocks are crashing, but not all biotech stocks are created equal. In fact, I think these three biotech stocks have something that every investor can get excited about: sales and profit growth. There's no telling where shares in ...
BIIB: 279.24 (+3.25), GILD: 100.27 (+2.73), CELG: 116.98 (+4.79)

The Good Side of Bad Jobs Report – Markets This Morning
Dana Blankenhorn - Amigobulls - Mon Oct 05, 1:08AM CDT
Markets ended up higher after initial decline on bad US job numbers. Markets are now betting on the idea that fed won't raise rates.
AMZN: 541.94 (+4.46), AMGN: 148.05 (+6.83), LLY: 83.99 (-0.18), MRO: 19.17 (unch), AAPL: 110.78 (-0.53), CELG: 116.98 (+4.79), APC: 69.14 (+0.49)

Facebook, Netflix Top Goldman Sachs' 2016 Growth List
at Investor's Business Daily - Fri Oct 02, 5:09PM CDT
Facebook's (FB) revenue growth in 2016 is seen decelerating compared to 2015 estimates, but it is No. 1 on Goldman Sachs' list of the 100 largest S&P 500 stocks ranked by growth, excluding financials and utilities. The social networking leader is...
NFLX: 108.10 (-0.23), AMZN: 541.94 (+4.46), FB: 92.40 (-0.40), ALXN: 164.78 (+4.78), BMY: 60.55 (+0.67), TWTR: 29.83 (+2.21), REGN: 485.76 (+25.94), CELG: 116.98 (+4.79), CRM: 75.00 (+0.58)

Celgene Rises 3.17% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 3:56PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $109.80 to a high of $116.50. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $113.08 on volume of 8.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 116.98 (+4.79)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 0

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 158

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 328

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 141

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Zadarma Unveils Innovative Multilingual AI Voice Assistant

Updated Category News Views 106

Introducing the Zadarma AI Voice Agent Zadarma, recognized for its exceptional VoIP services, has introduced an innovative virtual assistant - the Zadarma AI Voice Agent. This cutting-edge tool is designed to revolutionize customer interactions by providing seamless call handling, whether during traditional business hours or after hours. 24/7 Customer Support The Zadarma...

Continue Reading
Exploring Shift4 Payments Inc.'s P/E Ratio Trends and Insights

Updated Category News Views 199

Analyzing Shift4 Payments Inc. Stock Performance Shift4 Payments Inc. (NYSE: FOUR) is currently valued at $93.44, reflecting a decrease of 1.22% in today’s trading session. Despite this minor drop, there is good news: over the last month, the stock has climbed by 7.41%, and impressively, it has surged by 102.95% within the past year. This rapid appreciation has led many...

Continue Reading
SkyWest Insider Sells $2.01 Million Worth of Shares

Updated Category News Views 97

Wade J Steel Executes Major Sell Order of SkyWest Stock A significant insider transaction has come to light with Wade J Steel, Chief Commercial Officer at SkyWest (NASDAQ: SKYW), recently selling shares of the company worth $2.01 million. This transaction was documented through the latest SEC filing. Understanding the Sale The SEC filing revealed that Steel sold a total...

Continue Reading
Marpai Inc. to Discuss 2024 Financial Results in Upcoming Webcast

Updated Category News Views 140

Marpai Inc. Announces Webcast for Financial Results Marpai, Inc. is set to hold a conference call and webcast aimed at presenting vital operational and financial details surrounding its results for 2024. They are a leading technology platform company, operating as a respected Third-Party Administrator (TPA) within the health insurance sector. Marpai actively works to...

Continue Reading
Marex Group Investors Urged to Act Ahead of Critical Deadline

Updated Category News Views 160

Understanding the Legal Landscape for Marex Group Investors As an investor in Marex Group plc (NASDAQ: MRX), it's essential to stay informed and proactive regarding upcoming legal proceedings that may affect your investments. The Rosen Law Firm, a global leader in investor rights, has announced an important deadline for shareholders who purchased securities during a...

Continue Reading